CancerIQ officially launches lab network to increase awareness and accelerate adoption of genetic testing

CHICAGO, November 19, 2020 — CancerIQ, an enterprise precision health platform for cancer, has formed a network of trusted genetic labs to streamline and inform the genetic test ordering process. The CancerIQ Lab Network increases access to genetic testing and improves the experience for providers and genetic testing labs.

LabCorp is scheduled to present at the 2020 Evercore ISI 3rd Annual HealthCONx conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET.

Leading diagnostics companies join forces to establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)

WASHINGTON , Nov. 17, 2020 /PRNewswire/ -- Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. The current members of ACGP are Exact Sciences (NASDAQ: EXAS), Foundation Medicine, Illumina (NASDAQ: ILMN), LabCorp (NYSE: LH), QIAGEN (NYSE: QGEN), Roche Diagnostics (SIX: RO, ROG: OTCQX: RHHBY), and Thermo Fisher Scientific (NYSE: TMO).